Professor Hourihane replaces Professor David Kerins, former Dean of Medicine at UCC, who recently stepped down from these roles. "I’m pleased to welcome Professor Houihane to the Board of MMI and look forward to working with him to strengthen collaboration between our partners in clinical and translational research," Dr O’Connell said.
Professor Hourihane has been Professor of Paediatrics and Child Health at UCC since 2005. His primary area of clinical and research interest is in paediatric food allergy and anaphylaxis, with ongoing projects in clinical and proteomic characterisation of emerging food allergy syndromes, exploration of the link between skin barrier dysfunction and systemic allergic disorders, threshold doses of food allergens, immune-modulation of established allergic responses, prevention of allergic sensitisation including use of pre-and probiotic-enhanced infant formulae, and evaluation of quality of life in food allergic children. He is a co-investigator in the BASELINE study which is the first birth cohort study to be undertaken in Ireland in which babies are followed from birth and studied to determine why some go on to develop disease, whilst others remain healthy.
Professor Hourihane was a partner in the GA2LEN Network of Excellence and a member of the EU funded Europrevall Research Consortium (2005-2009) through which he contributed to the socio-economic evaluation of food allergy, focusing on its impact on quality of life. He is an associate editor of the journals Clinical and Experimental Allergy and Paediatric Allergy and Immunology.
Picture: Professor Jonathan Hourihane
